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ABSTRACT: Adiponectin is an adipocyte-derived adipokine with potent antidiabetic, anti-inflammatory, and anti-
atherogenic activity. Long-term, high-fat diet results in gain of bodyweight, adiposity, further inflammatory-based
cardiovascular diseases, and reduced adiponectin secretion. VitaminAderivatives/retinoids are involved in several
of these processes, whichmainly take place inwhite adipose tissue (WAT). In this study, we examined adiponectin
expression as a function of high dietary fat and high vitamin A conditions in mice. A decrease of adiponectin
expression in addition to an up-regulation of aldehyde dehydrogenase A1 (ALDH1A1), retinoid signaling, and
retinoic acid response element signaling was selectively observed in WAT of normal vitamin A– and high-fat
diet–fed mice. Reduced adiponectin expression in WAT was also observed in high vitamin A diet–fed mice.
Adipocyte cell culture revealed that endogenous and synthetic retinoic acid receptor (RAR)a- and RARg-selective
agonists, as well as a synthetic retinoid X receptor agonist, efficiently reduced adiponectin expression, whereas
ALDH1A1 expression only increased with RAR agonists. We conclude that reduced adiponectin expression under
high-fat dietary conditions is dependent on i) increased ALDH1A1 expression in adipocytes, which does not
increase all-trans-retinoic acid levels; ii) further RAR ligand–induced, WAT-selective, increased retinoic acid re-
sponse element–mediated signaling; and iii) RAR ligand–dependent reduction of adiponectin expression.—
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Obesity is considered to be one of the most common nu-
tritional disorders of Western society and is characterized
by a disproportionate expansion of body fat mass
[reviewed in Gasbarrini and Piscaglia (1)]. In addition to
being an energy storage site, white adipose tissue (WAT)
also functions as a highly active metabolic regulator and
ABBREVIATIONS:ALDH1A1, aldehyde dehydrogenase 1A1; ATRA, all-trans-retinoic acid; CTRL, control; FABP4, fatty acid binding protein 4; HF, high
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major endocrine organ that secretes various adipokines
(2–4). Adiponectin is a major adipokine with strong anti-
diabetic, anti-inflammatory, and antiatherogenic activity,
and its expression is decreased inWATunder highdietary
fat conditions [reviewed in Ouchi et al. (5)]. With the ex-
ception of the putative role of inflammation (6–8), the
precise mechanisms that mediate this down-regulation
remain to be elucidated.
Retinoids are important regulators of adipogenesis.
Diets that are high in vitamin A (9), excess of retinoic
acid (10, 11), and diet high in b-carotene (12–14), result
in increased adipocyte apoptosis and inhibition of
adipogenesis, while low concentrations of retinoic acid
were described to be proadipogenic (reviewed in refs.
9, 11, 15, 16). Retinoids [i.e., naturally occurring and
synthetic retinol analogues (reviewed in refs. 17, 18)],
are responsible for activation of specific nuclear re-
ceptors: the retinoic acid receptor (RAR) and the ret-
inoid X receptor (RXR). Bioactive retinoic acids are
formed from precursor retinaldehydes by the action
of retinaldehyde dehydrogenase enzymes (RALDHs/
ALDH1A) (19).
RALDH1/ALDH1A–null adult mice have been
shown to be resistant to high-fat diet–induced weight
gain (20, 21), which suggested that ALDH1A1 and its
metabolic products are necessary for high-fat diet–
induced obesity (22–24). ALDH1A1 can synthesize reti-
noic acids (25), such as all-trans-retinoic acid (ATRA),
9-cis-retinoic acid, and, presumably, the newly found
endogenous RXR ligand, 9-cis-13,14-dihydroretinoic
acid (26). The last 2 are ligands for both RXRs and
RARs, whereas ATRA only binds RAR. Unfortunately,
only a few studies have detected retinoic acids in low
concentrations in adipose tissue (27, 28), but no study
has addressed the presence of retinoic acids in WAT
when comparing ALDH1A1+/+ or ALDH1A12/2
mice. Whether retinoic acids, and which retinoic acids,
are the major metabolites of ALDH1A1 in WAT is yet
unknown. Moreover, ALDH1A1 expression has been
shown to be regulated by liver X receptor (LXR) (29) as
well as estrogen receptor–mediated pathways (30, 31).
Various nuclear hormone receptor pathways are in-
volved in adipokine secretion and adipocyte differentia-
tion, proliferation, and lipid accumulation (reviewed in
refs. 7, 32). In particular, RXRs, the central heterodimer-
forming partners, play important roles during obesity
(33–35). RXRa-KO as well as RXRg-KO mice and RXR-
antagonist treatment induce resistance to weight gain
after high-fat diet and also promote a higher metabolic
rate (36–38). RXRs can also interact with several nuclear
receptors, such as RAR, LXR, peroxisome proliferator-
activated receptor (PPAR), vitamin D receptor (VDR),
or NR4A-orphan nuclear receptors (39, 40), and the
activation of various so-called permissive heterodimers
(RXR-PPAR, -LXR, -VDR, and -NR4A1/2) by an RXR
ligand can initiate heterodimer-mediated signaling
(39–41).
The aim of our study was to find out how high-fat diet





Manually prepared diets were made with wheat starch
(Weizensta¨rke, Foodstar, Germany; provided byKro¨ner-Sta¨rke,
Ibbenbu¨ren, Germany), saccharose (purchased from a local
supermarket in Hungary), casein (Sigma-Aldrich, Budapest,
Hungary), cellulose (Vivapur; JRS Pharma GmbH; Rosenberg,
Germany), vitamin mix (Vitamin-Vormischung C1000;
Altromin GmbH, Lage, Germany), mineral mixture (Mineral-
Spurenelemente-Vormischung C100; Altromin GmbH), and
sunflower oil (Henry Lamotte, Bremen, Germany).
Animal experiments
Animal experiments were performed in the Laboratory Animal
Core Facility of the University of Debrecen. Experiments were
performed according to Hungarian ethical guidelines.
Experiment with low, normal, or high-fat supplementation
diets
After the acclimatization period, animals received a vitamin
A–deficient [0 retinol equivalents (RE)/kgdiet] diet for 10wk that
contained 5% sunflower oil as a dietary lipid, which represented
a diet with normal fat (NF) content (42). Animals were divided
into different feeding groups (n = 6 per group) and were fed for
4wkwith specificdiets that containeddifferent amountsofdietary
fat and equal amounts of vitamin A (2500 RE/kg diet, normal
vitamin A). Sunflower oil was added as dietary fat, which con-
tained either 2% [as weight %; low-fat (LF) diet], 5% (NF diet), or
25% [high-fat (HF) diet]. The source of the fat was always sun-
flower oil in different proportions added to feed. On the basis of
the analyzed feed of theNFdiet, it contained 11.6% saturated fats,
20% monounsaturated fatty acids, and 68.4% polyunsaturated
fatty acids (Weiss et al., in preparation). Furthermore, dietary
composition was 180 g/kg casein, 10 g/kg vitamin mix, 45 g/kg
mineral mix, and 20 g/kg cellulose for all applied diets (42). As a
result of the increased amount of fat in the diet, carbohydrate
proportion was lower; the low LF contained 29.5% sucrose and
43% starch, theNF diet 28% sucrose and 41.5% starch, and theHF
diet contained 17% sucrose and 32.5% starch (42).
Experiment with normal or high vitamin A supplementation
diets
For vitamin content, diets were supplemented with vitamin mix
(Vitamin-Vormischung C1000) that contained either 2500 RE/kg
as normal vitamin A diet, or for high vitamin A diets, an addi-
tional retinyl-palmitate (RetPal) supplement (final 326,500RE/kg;
Sigma-Aldrich) was added to the normal vitamin A diet (42, 43).
After euthanizing mice, blood collection was carried out by
cardiac puncture. Blood was centrifuged for 20 min and plasma
was stored at280°C. Mice were anatomized andWAT samples
were immediately frozen in liquid nitrogen after dissection and
later stored at280°C until RNA extraction.
Bioimaging
Retinoic acid response element (RARE)-Luc female mice (n = 6)
were obtained fromCgene (Oslo, Norway) and received LF, NF,
or HF diets for 4 wk or the oral retinoid treatments as described
before (43, 44).
We conducted ex vivo organ analysis by bioluminescence
imaging. All animals were treated with 120 mg/kg D-luciferin
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(Bioscience, Budapest, Hungary) via intraperitoneal injections 15
min before euthanasia and further organ screening. Mice were
euthanized by cervical dislocation. After sacrifice, mouse liver,
WAT, intestine, and brain were collected for bioluminescence
imaging. Organs were analyzed for bioluminescence signal by
using an Andor-Ixon CCD camera (Belfast, United Kingdom),
and analysis was performed by Andor-IQ software. After im-
aging, integrated intensity/area was calculated for liver, WAT,
intestine, and brain of each treated animal.
Cell culture
3T3-L1 preadipocytes (American Type Culture Collection,
Manassas, VA, USA)were seeded in 3.5-cm-diameter dishes at a
density of 153 104 cells/well. Cells were grown in DMEM that
was supplementedwith 10%FBSat 37°C in a5%CO2humidified
atmosphere, as previously reported (45, 46). To induce differen-
tiation, 2-d postconfluent 3T3-L1 preadipocytes (day 0) were
stimulated for 48 h with 0.5 mM isobutylmethylxanthine, 0.25
mM dexamethasone, and 1 mg/ml insulin in DMEM that was
supplemented with 10% FBS. Cells were then maintained in
DMEM that was supplemented with 10% FBS and 1 mg/ml in-
sulin (47). To examine the effects on gene expression of ATRA (a
gift from BASFAG, Ludwigshafen, Germany), an RARa agonist
(BMS753), an RARg agonist (BMS189961; both were prepared in
our laboratories as described in the original patents (48, 49)], and
an RXR agonist (LG268; gift from Ligand Pharmaceuticals, San
Diego, CA, USA), 3T3-L1 adipocytes were incubated with 1 mM
of these molecules for 24 h, as previously reported (47). Data
presented are the mean of 3 independent experiments each per-
formed in triplicate.
Human adipose biopsies
Eleven lean (body mass index: 22.5 6 0.5 kg/m2) and 14 obese
(body mass index: 31.7 6 0.9 kg/m2) male participants were
recruited, aspreviously reported (50). Leanandobesevolunteers
were age 44 6 7 y and 44 6 5 y, respectively. Subcutaneous
adipose tissue biopsies were performed between 6:30 AM and
7:30 AM after an overnight fast. Biopsies were obtained by
needle aspiration in the periumbilical area under local anesthe-
sia. Adipose tissue samples were rinsed in physiologic serum,
immediately frozen in liquid nitrogen, and stored at280°Cuntil
RNA extraction. The experimental protocol was performed in
accordance with the guidelines in the Declaration of Helsinki
and was approved by the Ethical Committee of the Auvergne
Region (agreement No. AU 800, March 2010). Participants gave
their written informed consent to participate in the study.
Analysis of mRNA expression
Analysis of total cellular RNA extracted from 3T3-L1 cells was
performed in France by using Trizol reagent according to man-
ufacturer instructions. Human adipose tissue sample extraction
was also performed in France, whereas WAT and liver sample
analysis from mice was done in Hungary.
For the cell culture material in the French laboratory, cDNA
was synthesized from1mgof totalRNAin20ml byusingrandom
primers and Moloney murine leukemia virus reverse transcrip-
tase. Real-time quantitative RT-PCR analyses for genes were
performed by using the Mx3005P Real-Time PCR System (Stra-
tagene, La Jolla, CA, USA) as previously described (51). For each
sample, expression was quantified in duplicate and 18S rRNA
was used as the endogenous control in the comparative cycle
threshold (CT) method.
ForWATand liver tissue analysis of human andmurine origin,
tissues were homogenized in Tri reagent solution (Thermo Fisher
Scientific, Waltham, MA, USA) and total RNA was isolated from
tissue according to manufacturer guidelines and as previously de-
scribed (52). Concentration and purity of RNA was measured
by using theNanoDrop spectrophotometer (Thermo Fisher Scientific).
For real-time quantitative PCR, total RNA was reverse tran-
scribed into cDNA by using the Super Script II First-Strand
Synthesis System (Thermo Fisher Scientific). Quantitative real-
time PCR was carried out in triplicate using predesigned MGB
assays (Thermo Fisher Scientific) on anABI Prism 7900 (Applied
Biosystems, Villebon-sur-Yvette, France). Relative mRNA levels
were calculated by using the Ct method and were normalized
to cyclophilin A mRNA. Sequence Detector Software (v. 2.1;
Applied Biosystems) was used for data analysis.
Analytical procedures
WAT samples were collected and stored in dark vials at280°C
until analysis. Sample preparation was performed as previously
described for retinoid (53) and eicosanoid/docosanoid (54)
analysis. HPLC–tandem mass spectrometry analyses for ret-
inoids as well as eicosanoids and docosanoids, which focused
on eicosanoids with known PPAR activation potential, were
also performed as previously explained (53, 54).
ELISA assays
To examine the effect of retinoids on adiponectin secretion,
3T3-L1 adipocytes were incubated with 1 mM of the retinoids
(ATRA, RARa, RARg, or RXR ligand) for 48 h. Adiponectin
quantification was realized on the culture supernatant by using
adiponectin ELISA assay according to manufacturer protocol
(Quantikine ELISA; R&D Systems, Lille, France).
Statistics
Data are expressed as means 6 SEM. Significant differences be-
tween control and treated cells/groups were determined by
Student’s t test using Statview software (SAS Institute, Cary,NC,
USA). Values of P, 0.05 were considered significant.
RESULTS
Effects of HF diet on body weight gain
Body weight gain was observed in animals after 4 wk
of HF diet compared with LF or NF diet supplementa-
tion (LF: 1.076 0.08 g;NF: 0.926 0.11 g;HF: 3.246 0.37 g;
LF-HF P = 0.03 and NF-HF P = 0.04). Food intake slightly
decreased in the HF diet group (LF: 2.93 g/d/animal; NF:
2.70 g/d/animal; HF: 2.25 g/d/animal).
Supplementation of HF diet results in up-
regulation of ALDH1A1 and down-regulation
of adiponectin expression
ALDH1A1 was significantly increased only in WAT (LF:
1 6 0.80; NF: 1.83 6 0.36; HF: 5.26 6 0.23) of HF diet–
supplemented mice compared with LF diet– and NF
diet–fedmice and tissue selective forWAT (Table 1,WAT)
comparedwith unchanged expression in the liver (Table 1,
liver). ALDH1A2 expression remained unchanged in liver
and WAT (Table 1). ALDH1A3 was also significantly
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increased in adipose tissue of HF diet– and NF diet–fed
animals comparedwith LF (Table 1,WAT). In addition,
expression of RAR pathway target genes, such as
CYP26A1 and CYP26B1, remained unchanged (Table 2),
whereas expression of the highly sensitive common
RAR/RXRpathway target gene transglutaminase2 (TG2)
was strongly increased (Table 1; LF: 16 0.36; NF: 9.566
0.13; HF: 15.366 0.17) in HF diet–supplemented mice.
In addition to increased retinoid signaling, expression
of adiponectin was reduced in HF diet–fed mice (LF: 16
0.31; NF: 0.866 0.12; HF: 0.156 0.37).
Increased ALDH1A1 and reduced adiponectin
expression in obese volunteers
Experiments using adipose tissue biopsies from normal
weight and obese human volunteers confirmed increased
ALDH1A1 (healthy volunteers were set as 1; 1.206 0.07)
and reduced adiponectin (0.85 6 0.04) expression in the
obese volunteers (Table 3).
High vitamin A–supplemented diet results in
increased expression of ALDH1A1 and reduced
adiponectin expression
ExpressionofALDH1A1 increased (NF,normalvitaminA
was set as 1: 16 0.19; NF, high vitamin A: 2.326 0.47) in
the WAT of high vitamin A– and NF diet–supplemented
mice with NF content, whereas adiponectin expression
(NF, normal vitamin A was set as 1: 1 6 0.47; NF, high
vitamin A: 0.376 0.21) was decreased in WAT (Table 4).
Decreased retinoic acid concentrations
present in WAT of HF diet–supplemented
animals do not correspond to increased RARE-
mediated signaling in RARE-Luc mice, and
PPARg ligands remain mainly unchanged
Retinol levels remainedstable in theWATofLF-,NF-, and
HF-supplemented animals, whereas ATRA (LF: 2.26 0.1
ng/g; NF: 1.76 0.2 ng/g; HF: 0.66 0.1 ng/g) levels were
lower in the WAT of HF diet–supplemented animals
(Table 5).
Increased retinoid signaling was confirmed in RARE-
Luc mice, with increased RARE-mediated signaling de-
tected specifically in adipose tissue of HF diet– compared
with LF and NF diet–supplemented animals, whereas in
liver, intestine, and brain, no increased RARE-mediated
signaling was observed (Fig. 1).
Endogenous PPAR ligands [9-hydroxyoctadecadienoic
acid (HODE), 13-HODE, 13-keto-octadecadienoic acid,
12-keto-eicosatetraenoic acid, PgJ2 and d15d12PgJ2] were
mainly unchanged, except the adipose tissue–specific
PPARg ligand, hepoxilin B3,which is increased in adipose
tissue of HF diet–supplemented animals (Table 5).
TABLE 1. Relative adiponectin and ALDH1A1 mRNA expression
Gene
Fold activation Signiﬁcance
LF NF HF LF:NF NF:HF LF:HF
WAT
ALDH1A1 1 6 0.80 1.83 6 0.36 5.26 6 0.23 0.46 0.05 0.01
ALDH1A2 1 6 0.11 1.05 6 0.14 1.09 6 0.19 0.77 0.87 0.69
ALDH1A3 1 6 0.17 1.65 6 0.08 2.59 6 0.24 0.03 0.12 0.02
Adiponectin 1 6 0.31 0.86 6 0.12 0.15 6 0.37 0.72 ,0.01 0.04
Liver
ALDH1A1 1 6 0.10 1.10 6 0.11 1.39 6 0.13 0.53 0.64 0.09
ALDH1A2 1 6 0.12 0.79 6 0.09 0.74 6 0.10 0.17 0.64 0.09
Expression shown in WAT and liver of LF (set as 1), NF, and HF diet–fed mice with a normal content
of vitamin A in the diet. Gene expression (all n = 6) of adiponectin and retinoic acid synthesizing
enzymes (ALDH1A1, ALDH1A2, ALDH1A3). Signiﬁcant values vs. LF are in italics.
TABLE 2. Relative gene expression of genes involved in RAR and PPAR signaling in mouse WAT
Gene
Fold activation Signiﬁcance
LF NF HF LF:NF NF:HF LF:HF
RAR pathway
CYP26A1 1 6 0.50 0.16 6 0.41 0.43 6 0.49 0.13 0.26 0.33
CYP26B1 1 6 0.63 0.58 6 0.52 0.93 6 0.66 0.60 0.65 0.94
TG2 1 6 0.36 9.56 6 0.13 15.36 6 0.17 ,0.01 0.08 ,0.01
PPAR pathway
PPARg 1 6 0.12 1.23 6 0.09 0.93 6 0.09 0.18 0.07 0.67
RETSAT 1 6 0.21 1.96 6 0.23 1.38 6 0.26 0.09 0.37 0.37
FABP4 1 6 0.03 1.00 6 0.10 1.08 6 0.10 0.99 0.57 0.47
FADS2 1 6 0.43 1.31 6 0.41 1.46 6 0.48 0.71 0.88 0.64
Expression in WAT of LF (set as 1), NF, and HF diet–fed mice with a normal content of vitamin A in
diet (all n = 6). Signiﬁcant values vs. LF are in italics.
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NF and HF diet supplementation does not
result in altered PPARg-mediated signaling
Expression of PPARg and PPARg target genes reti-
nol saturase (RETSAT)/fatty acid binding protein 4
(FABP4)/FADS2 remained unaffected by NF- and HF-
supplemented diet compared with LF-supplemented
diet in mouse WAT (Table 2).
Adiponectin expression is reduced by RAR and
RXR agonists using 3T3-L1 adipocytes
cell culture
Treatment of cultured adipocytes with synthetic RARa-
selective ligands [control (CTRL) set as 1; adiponectin:
0.22 6 0.01 and ALDH1A1 2.37 6 0.04], RARg-selective
ligands (CTRL set as 1; adiponectin: 0.22 6 0.01 and
ALDH1A1 2.64 6 0.01), and the natural RAR ligand
ATRA (CTRL set as 1; adiponectin: 0.25 6 0.03 and
ALDH1A1 3.19 6 0.07), in addition to a synthetic RXR
agonist (LG268; CTRL set as 1; adiponectin: 0.51 6 0.04
and ALDH1A1 1.04 6 0.04), resulted in increased
ALDH1A1 expression for RAR agonists, whereas adipo-
nectin expression was reduced for all RAR and RXR li-
gands. In addition, these results were confirmed at the
protein level in cell culture supernatants where adipo-
nectin secretionwas reduced forall administeredRARand
RXR ligands, except for the RARg-selective ligand, which
displayed a nonsignificant decrease (Table 6).
DISCUSSION
Obesity is classically associated with a decrease of adi-
ponectin plasma level in humans and rodents, as well
as a decreased expression in adipose tissue (5). This re-
lationship between obesity and decreased adiponectin
expression is suspected to be linked to the increased in-
flammatory status of adipose tissue, as TNF-a, one of the
main inflammatorymarkers produced by adipose tissue
(55), is known to reduce adiponectin expression (56).
However, this mechanism is probably not exclusive, and
other pathways—RARsignaling among them—couldbe
involved in this regulation.
In this study, we reported that, in mice, reduced adipo-
nectinexpression inWATafterHFdietsupplementationwas
associatedwithan increaseofALDH1A1expression. Similar
resultswere also obtainedby comparing lean vs.obeseWAT
biopsies. Surprisingly, increased ALDH1A1 expression in
mice does not result in increased ATRA levels in WAT.
ALDH1A1, the major enzyme for retinoic acid synthesis
using retinaldehyde as a substrate, is highly likely to play an
important role in the relationship between retinoid signaling
and obesity (20, 21, 57). Indeed, its expression is increased in
WAT during HF-induced obesity (58). In ALDH1A12/2-
deficient adipocytes as well as in ALDH1A12/2mice,
adipogenesis is impaired and mice are resistant to HF
diet–inducedobesity (20),which issuggestedtoberelatedto
alteredretinoidsignaling [(25)andreviewed in refs. 9, 11, 15].
Retinoic acids, the products from ALDH1A1 metabolism,
are the endogenous activators of RARs and RXRs. Reduced
retinaldehyde and retinol levels were measured in adipose
tissue of HF diet–supplemented animals, and ATRA levels
were speculated to be increased upon ALDH1A1 activity
(20). However, the detection and quantification of retinoic
acid levels inadipose tissuehavebeenscarcelyexamined(27,
28) and, unfortunately, the connection of retinoic acids in
response toALDH1A1expression in adipose tissue has not
been studied before. In the present study, we report that
increased ALDH1A1 expression in mice does not result in
increased ATRA levels in WAT. On the contrary, ATRA
levels were even lower in WAT of HF vs. LF or NF diet–
supplemented animals. Similar reduced levels of ATRA
were confirmed in serum and adipose tissue of obese
volunteers comparedwith obese volunteers after a weight
lossdiet (unpublisheddata),which indicates that obesity is
related to reduced local and systemic retinoid levels in
humans. These findings of reduced local retinoid levels in
adipose tissue of obese animals fit well with previous
studies on vitamin A–deficient diet–fed animals, which
were found to become obese upon reduced ATRA syn-
thesis, levels, andATRA-mediated signaling [reviewed in
Bonet et al. (11)]. In addition, it is well established that
retinoids, andespeciallyATRA, as signaling ligands, have
the ability to inhibit proliferation of adipocytes; enhance
up-regulation of genes involved in lipid oxidation, en-
ergy dissipation, and insulin response; and thereby
preventobesityand insulin resistance [reviewed inBonet et
al. (11)], probably by targeting adipocyte oxidative phos-
phorylation and mitochondriobiogenesis (59).
As a result of this unclear evidence and inconclusive
determination of retinoic acids levels in WAT, we opted,
like others [(21, 57) plus follow-up reviews (15, 22)], for an
indirectmethod of detection of retinoid signaling by using
a RARE-reporter mouse model (44) and we confirmed
increasedWAT-selective,RARE-mediated signaling in the
WAT of HF diet– vs. LF diet–fed mice (57). Previous ex-
perimental studies claimed, without any analytical proof,
TABLE 4. Relative adiponectin and ALDH1A1 mRNA expression








ALDH1A1 1 6 0.19 2.32 6 0.47 0.05
Adiponectin 1 6 0.47 0.37 6 0.21 0.02
Expression in WAT of normal vitamin A and high vitamin A
diet–fed mice with a NF diet (set as 1; n = 6). Signiﬁcant values vs. NF,
normal vitamin A are in italics.
TABLE 3. Relative expression of human adiponectin and ALDH1A1
in WAT in humans
Gene
Fold activation
SigniﬁcanceNV (n = 20) OB (n = 26)
ALDH1A1 1.00 6 0.08 1.20 6 0.07 0.03
Adiponectin 1.00 6 0.04 0.85 6 0.04 0.01
Expression in WAT of obese (OB) and normal volunteers (NV).
Signiﬁcant values vs. NV are in italics. NV was calculated to be set as 1.
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the involvement of ALDH1A1-synthesized ATRA in adi-
pose tissue and, only on the basis of increased RARE sig-
naling (21, 57), that ATRA is the metabolite of ALDH1A1
in adipose tissue and that the described effects of
ALDH1A1,by consequence, aremediatedbyATRA-RAR
signaling. Furthermore, they claimed that the ALDH1A1
product ATRA must be involved in the ALDH1A1-
mediated increase of adipose tissue expansion and diet-
induced obesity. Our solid data, generated by using
HPLC–tandemmass spectrometry quantification of ATRA
in adipose tissue, contradicts these claims andwarns about
the common obtainment of false-positive data fromRARE-
Luc activation models (60).
We concluded that either a still-uncharacterized endog-
enous RAR ligand must be synthesized in the WAT of HF
diet–supplemented mice to induce WAT-selective, RARE-
mediated signalingor alternativemechanisms thatpossibly
involve transporter protein–mediated signaling [reviewed
in (61) and speculated by (62)] or post-translational modi-
fications in adipocytes [(21) and reviewed in ref. 63] must
be taken into consideration.With regard to ligands other
than ATRA, it is still unknown which RAR- and/or
RXR-activating ligands could be synthesized upon
ALDH1A1 expression in WAT, and we could not
conclusively suggest a possible structure using our current
analytical expertise (26, 53). However, several known and
unknown candidates, including 9-cis- and all-trans-13,14-
dihydroretinoic acid, retinal, apo-lycopenoic acids, apo-139-
carotenone, apo-109-carotenoic acid, and apo-149-carotenoic
acid (20, 26, 44, 47, 64–72)were recently identified and could
constitute potential endogenous retinoids.
To further exclude the involvement of PPARg, the
key regulator of adipogenesis (7, 73), as a major nuclear
receptor responsible for adiponectin reduction after a
HF-supplemented diet, endogenous PPAR ligands were
determined. Levels in adipose tissue were mainly un-
altered after LF, NF, or HF diet supplementation (74–77).
Only the levels of the endogenous and adipose tissue–
specific PPARg ligand, hepoxilin B3, (78, 79) were signif-
icantly increased in HF diet– vs. LF diet–supplemented
animals. In addition, our data show no increased expres-
sion of PPARg and known PPARg target genes, RETSAT,
FABP4,andFADS2, in theWATofHFdiet–supplemented
mice, which, in part, contrasts with previous studies. In
general, increasedPPARg expression inadipose tissueafter
HF diet is mainly related to omental and not subcutaneous
fat inhumans,as reviewed in (80). Inmice, increasedPPARg
expression is observable just after diets with extreme
Figure 1. Integrated intensity areas of bioluminescence imaging of various organs of RARE-LUC mice (n = 6) that were fed with
LF, NF, and HF diets, with normal vitamin A content in the diet. The line over the bars indicates statistical signiﬁcance.
TABLE 5. HPLC–tandem mass spectrometry analysis of retinoids and eicosanoids in WAT
Compound
Levels (ng/g) Signiﬁcance
LF NF HF LF:NF NF:HF LF:HF
Retinoid
ATRA 2.2 6 0.1 1.7 6 0.2 0.6 6 0.1 0.19 0.01 ,0.01
ROL 1461 6 97 1591 6 94 1520 6 50 0.35 0.38 0.41
Eicosanoid
13-HODE 557 6 46 605 6 79 803 6 83 0.40 0.21 0.11
9-HODE 186 6 17 157 6 18 211 6 27 0.29 0.22 0.35
13-KODE 228 6 18 674 6 266 433 6 95 0.22 0.34 0.16
12-KETE 10.3 6 2.4 7.6 6 1.1 19.6 6 4.6 0.31 0.12 0.20
PgJ2 0.2 6 0.0 0.4 6 0.0 0.2 6 0.2 0.08 0.09 0.44
d15d12PgJ2 UQL UQL UQL
HXB3 0.5 6 0.2 2.2 6 0.5 5.3 6 1.1 0.08 0.13 0.03
Analysis of retinoids, ATRA and retinol, as well as the endogenous relevant PPAR ligands, 13-HODE,
9-HODE, 13-keto-octadecadienoic acid (KODE), 12-keto-eicosatetraenoic acid (KETE), PgJ2,
d15d12PgJ2, and hepoxilin B3 (HXB3); all in ng/g 6 SEM of WAT samples from LF, NF, and HF
diet–fed mice with a normal content of vitamin A in diet (all n = 4). Signiﬁcant values vs. LF are in italics.
ROL, retinol; UQL, under the quantiﬁcation limit.
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HF conditions, strong weight gain, and after a long time
of HF diet supplementation (,8 wk) (81–84). Finally, it is
well established that PPARg signaling activation in-
creases secretion of adiponectin rather than decreases it
(85). In summary, all these data strongly imply that
PPARg-mediated signaling in adipose tissue of HF diet–
supplemented animals is unlikely to be of major impor-
tance for further reduced adiponectin expression.
To evaluate RAR- and RXR-mediated signaling path-
ways in adipocytes directly, 3T3-L1 adipocyte cell culture
models were used, and we determined that ALDH1A1
was increased after administration ofATRA and synthetic
RARa- and RARg-selective RAR ligands, and not by a
synthetic RXR ligand, whereas adiponectin expression
and secretion in the cell supernatant were decreased after
administration of RAR or RXR agonists. We conclude,
therefore, that this direct down-regulation of adiponectin
is anRAR-orRXR-mediatedpathwayand thatALDH1A1
expression is regulated by an RAR ligand.
In summary (Fig. 2), we found that reduced adiponectin
expression in the WAT of mice is under the control of
retinoid-mediated signaling, mainly via RAR-mediated
signaling pathways. We suggest that altered retinoid sig-
naling in adipose tissue is an important mechanism of HF
diet–induced obesity. In particular, ALDH1A1 seems to be
the key enzyme that is responsible for the synthesis of al-
ternative endogenousRARligands selectively inWAT.This
increased ALDH1A1 and reduced adiponectin expression
was also confirmed to occur in adipose tissue from obese
human volunteers. Endogenous as well as synthetic RAR
ligands were shown to further directly inhibit adiponectin
expression in cultured adipocytes. The nature of the en-
dogenous RAR/RXR agonists or antagonists synthesized
by ALDH1A1 in WAT remains elusive and is the topic of
future studies. Characterization of these novel endogenous
retinoidswithmainlyRAR, aswell as potential RXR, ligand
activation potential and their metabolic pathways can help
clarify the controversy of the altered retinoid signaling in
adipose tissue. On the basis of these data, novel strategies
can be developed to selectively inhibit distinct retinoid sig-
naling, especially that which involves ALDH1A1 products
underHFdiet, focusedonadipose tissue to enable sufficient
beneficial adiponectin expression.
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